{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:21:24Z","timestamp":1770704484277,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1136\/ard.51.2.286","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"286-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["A brief overview of the pathogenesis of scleroderma (systemic sclerosis)."],"prefix":"10.1016","volume":"51","author":[{"given":"E.C","family":"LeRoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","article-title":"textbook of medicine","author":"LeRoy E C. Systemic sclerosis (scieroderma). In, Wvngaarden J B","unstructured":"LeRoy E C. Systemic sclerosis (scieroderma). In: Wvngaarden J B, et al, eds. Cecil textbook of medicine. 19th ed. Philadelphia: Saunders. In press.","edition":"19th ed"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinucleolar antibodies: diagnostic markers for autoimmune diseases and probes for cellular biology","volume":"44","author":"M, Tan E.","year":"1989","unstructured":"Tan E M. Antinucleolar antibodies: diagnostic markers for autoimmune diseases and probes for cellular biology. Adv Immunol 1989; 44: 93-151.","journal-title":"Adv Immunol"},{"key":"ref_3","first-page":"19","article-title":"The immune basis for human fibrotic diseases, especially scleroderma (systemic sclerosis)","volume":"3","author":"B, Kahaleh M.; C, LeRoy E.","year":"1989","unstructured":"Kahaleh M B, LeRoy E C. The immune basis for human fibrotic diseases, especially scleroderma (systemic sclerosis). ClinicalAspects ofImmunology 1989; 3: 19-28.","journal-title":"ClinicalAspects ofImmunology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0889-857X(21)01040-1","article-title":"Vascular disease in scleroderma. Endothelial-T lymphocyte-fibroblast interactions","volume":"16","author":"B, Kahaleh M.","year":"1990","unstructured":"Kahaleh M B. Vascular disease in scleroderma. Endothelial-T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am 1990; 16: 53-73.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.1780280708","article-title":"Cellular immunity to collagen and laminin in scleroderma","volume":"28","author":"E, Huffstutter J.; A, DeLustro F.; C, LeRoy E.","year":"1985","unstructured":"Huffstutter J E, DeLustro F A, LeRoy E C. Cellular immunity to collagen and laminin in scleroderma. Arthritis Rheum 1985; 28: 775-80.","journal-title":"Arthritis Rheum"},{"key":"ref_6","first-page":"8492","article-title":"Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase-I: sequence similarity with retroviral p30 gag protein suggests a possible cause for autoimmunity","volume-title":"systemic sclerosis. Proc Natl Acad Sci","volume":"86","author":"G, Maul G.; A, Jimenez S.; E, Riggs; D, Ziemnicka-Kotula","year":"1989","unstructured":"Maul G G, Jimenez S A, Riggs E, Ziemnicka-Kotula D. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase-I: sequence similarity with retroviral p30 gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci USA 1989; 86: 8492-6."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.1780340510","article-title":"Increased interleukin 2 production in response to human type I collagen stimulation in patients with systemic sclerosis","volume":"34","author":"Hawrylko, E.; Spertus, A.; A, Mele C.; Oster, N.; Frieri, M.","year":"1991","unstructured":"Hawrylko E, Spertus A, Mele C A, Oster N, Frieri M. Increased interleukin 2 production in response to human type I collagen stimulation in patients with systemic sclerosis. Arthritis Rheum 1991; 34: 580-7.","journal-title":"Arthritis Rheum"},{"key":"ref_8","first-page":"129","article-title":"Enhanced lymphocyte-endothelial cell (EC) interaction in scleroderma (SSc)","volume":"33","author":"B, Kahaleh M.; T, Yin","year":"1990","unstructured":"Kahaleh M B, Yin T. Enhanced lymphocyte-endothelial cell (EC) interaction in scleroderma (SSc) [abstract]. Arthritis Rheum 1990; 33 (suppl):A129.","journal-title":"Arthritis Rheum"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/346425a0","article-title":"Adhesion receptors of the immune system","volume":"346","author":"A, Springer T.","year":"1990","unstructured":"Springer T A. Adhesion receptors of the immune system. Nature 1990; 346:425-34.","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.170.4.1133","article-title":"Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex and anti-CD3 antibody","volume":"170","author":"Matsuyama, T.; Yamada, A.; Kay, J.","year":"1989","unstructured":"Matsuyama T, Yamada A, Kay J, et al. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex and anti-CD3 antibody.JExpMed 1989; 170: 1133-48.","journal-title":"JExpMed"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.172.2.649","article-title":"Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family","volume":"172","author":"H, Dang N.; Y, Torimoto; F, Schlossman S.; C, Morimoto","year":"1990","unstructured":"Dang N H, Torimoto Y, Schlossman S F, Morimoto C. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. JExp Med 1990; 172: 649-52.","journal-title":"JExp Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1083\/jcb.109.3.1321","article-title":"Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin","volume":"109","author":"A, Wayner E.; A, Garcia-Pardo; J, Humphries M.; A, McDonald; G, Carter W.","year":"1989","unstructured":"Wayner E A, Garcia-Pardo A, Humphries M J, McDonald A, Carter W G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989; 109:1321-30.","journal-title":"J Cell Biol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1096\/fasebj.4.2.2404817","article-title":"Structure and function of laminin: anatomy of a multidomain glycoprotein","volume":"4","author":"Beck, K.; Hunter, I.; Engel, J.","year":"1990","unstructured":"Beck K, Hunter I, Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEBJ 1990; 4:148-60.","journal-title":"FASEBJ"},{"key":"ref_14","first-page":"2598","article-title":"What distinguishes tenascin from fibronectin","volume-title":"FASEBJ","volume":"4","author":"Chiquet-Ehrismann, R.","year":"1990","unstructured":"Chiquet-Ehrismann R. What distinguishes tenascin from fibronectin. FASEBJ 1990; 4:2598-604."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/jimmunol.145.1.59","article-title":"Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin","volume":"145","author":"Shimizu, Y.; van Seventer G A; J, Horgan K.; Shaw, S.","year":"1990","unstructured":"Shimizu Y, van Seventer G A, Horgan K J, Shaw S. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 1990; 145: 59-67.","journal-title":"J Immunol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.iy.08.040190.002053","article-title":"VLE proteins in the integrin family: structures, functions and their role on leukocytes","volume":"8","author":"E, Hemler M.","year":"1990","unstructured":"Hemler M E. VLE proteins in the integrin family: structures, functions and their role on leukocytes. Annu Rev Immunol 1990; 8: 365-400.","journal-title":"Annu Rev Immunol"},{"key":"ref_17","first-page":"7437","article-title":"Tenascin, an extracellular matrix protein, exerts immunomodulatory activities","volume-title":"Proc NatlAcad Sci USA","volume":"86","author":"R, Regg C.; R, Chiquet-Ehrismann; S, Alkan S.","year":"1989","unstructured":"Regg C R, Chiquet-Ehrismann R, Alkan S S. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc NatlAcad Sci USA 1989; 86: 7437-41."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Presence of interleukin 2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"B, Kahaleh M.; C, LeRoy E.","year":"1989","unstructured":"Kahaleh M B, LeRoy E C. Presence of interleukin 2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989; 110:446-50.","journal-title":"Ann Intern Med"},{"key":"ref_19","first-page":"1326","article-title":"Endothelial injury in scleroderma","volume":"149","author":"Kahaleh, M.B.; K, Sharer G.; C, LeRoy E.","year":"1979","unstructured":"Kahaleh MB, Sharer G K, LeRoy E C. Endothelial injury in scleroderma. IExpMed 1979; 149:1326-35.","journal-title":"IExpMed"},{"key":"ref_20","first-page":"553","article-title":"Endothelial injury in scleroderma. A protease mechanism","volume":"101","author":"Kahaleh, M.B.; C, LeRoy E.","year":"1983","unstructured":"Kahaleh MB, LeRoy E C. Endothelial injury in scleroderma. A protease mechanism. J Lab Clin Med 1983; 101: 553-60.","journal-title":"J Lab Clin Med"},{"key":"ref_21","first-page":"67","article-title":"The molecular mechanism of endothelial cell (EC) injury in scleroderma (SSc): identification of granzyme 1 (a product of cytolytic T cell) in SSc sera","volume":"33","author":"B, Kahaleh M.","year":"1990","unstructured":"Kahaleh M B. The molecular mechanism of endothelial cell (EC) injury in scleroderma (SSc): identification of granzyme 1 (a product of cytolytic T cell) in SSc sera [abstract]. Arthritis Rheum 1990; 33 (suppl): 67.","journal-title":"Arthritis Rheum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynaud's phenomenon","volume":"94","author":"B, Kahaleh M.; I, Osborn; C, LeRoy E.","year":"1981","unstructured":"Kahaleh M B, Osborn I, LeRoy E C. Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynaud's phenomenon. Ann Intern Med 1981; 94:482-4.","journal-title":"Ann Intern Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.135.6.1351","article-title":"Connective tissue synthesis by scleroderma skin fibroblasts in cell culture","volume":"135","author":"C, LeRoy E.","year":"1972","unstructured":"LeRoy E C. Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. JExp Med 1972, 135: 1351-62.","journal-title":"JExp Med"},{"key":"ref_24","first-page":"477","article-title":"Elevated expression of c-myc protooncogene in scleroderma fibroblasts","volume":"3","author":"Trojanowska, M.; Wu, L.; C, LeRoy E.","year":"1988","unstructured":"Trojanowska M; Wu L, LeRoy E C. Elevated expression of c-myc protooncogene in scleroderma fibroblasts. Oncogene 1988; 3:477-81.","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jcp.1041450124","article-title":"Mitogenic effects of transforming growth factor P11 on human fibroblasts involves the induction of platelet-derived growth factor (L receptors","volume":"145","author":"Ishikawa 0, LeRoy E C, Trojanowska M","year":"1990","unstructured":"Ishikawa 0, LeRoy E C, Trojanowska M. Mitogenic effects of transforming growth factor P11 on human fibroblasts involves the induction of platelet-derived growth factor (L receptors. J Cell Physiol 1990; 145: 181-6.","journal-title":"J Cell Physiol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/j.2326-5205.1989.tb00012.x","article-title":"A strategy for scleroderma (systemic sclerosis): is transforming growth factor beta the answer?","volume":"32","author":"C, LeRoy E.; A, Kahaleh M.B.; M, Trojanowska; M, Silver R.","year":"1989","unstructured":"LeRoy E C, Smith E A, Kahaleh M B, Trojanowska M, Silver R M. A strategy for scleroderma (systemic sclerosis): is transforming growth factor beta the answer? Arthritis Rheum 1989; 32: 817-25.","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.51.2.286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:16:43Z","timestamp":1738304203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724103433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["S0003496724103433"],"URL":"https:\/\/doi.org\/10.1136\/ard.51.2.286","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1992,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief overview of the pathogenesis of scleroderma (systemic sclerosis).","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.51.2.286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}